Clinicians develop model to calculate patient risk for NAFLD decompensation

Non-alcoholic fatty liver disease (NAFLD) is one of the most common liver diseases worldwide and is associated with conditions such as obesity and metabolic syndrome, which can lead to diabetes, stroke, and heart disease. Although common, identifying people who could be at risk for NAFLD decompensation can be challenging for physicians. “We needed a way […]

53rd Annual Internal Medicine Research Day, 10/15/19

Since the tradition began in the early 1960s, Research Day has seen a variety of formats. But what has always been at its core was the celebration of the diversity and depth of the work being done by a panoply of trainees, clinicians, and basic scientists. Better understanding a disease mechanism or testing a new […]

Link between systems leading to hypertension described

Previous studies have found that manipulating renal nerves could serve as a hypertension therapeutic in cases where pharmacological treatment is ineffective. Sailesh Harwani, MD, PhD, assistant professor in Cardiovascular Medicine, has conducted the first study that suggests the integration of adrenegic, cholingeric, and renal systems affects the development of premature hypertension. His study also is […]

Faraci Receives $2.54M R01

Frank Faraci, PhD, Professor in the Division of Cardiovascular Medicine and of Pharmacology, received a five-year, $2.54M R01 grant from the National Institutes of Health (NIH). Dr. Faraci plans to use these funds to study small vessel disease (SVD) in the brain to gain insight into mechanisms and potential therapies that could prevent this group […]